Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med., 12 November 2021
Sec. General Cardiovascular Medicine
This article is part of the Research Topic Advances in The Prevention and Rehabilitation of Cardiovascular Diseases via Aerobic Exercise View all 24 articles

Acute Hemodynamic Responses to Enhanced External Counterpulsation in Patients With Coronary Artery Disease

\nYahui Zhang,,Yahui Zhang1,2,3Ziqi Chen,Ziqi Chen1,2Zhouming MaiZhouming Mai4Wenjuan ZhouWenjuan Zhou1Hui WangHui Wang5Xiaodong ZhangXiaodong Zhang6Wenbin WeiWenbin Wei1Jianhang Du,,
Jianhang Du1,2,3*Guifu Wu,,
Guifu Wu1,2,3*
  • 1Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
  • 2National Health Commission (NHC) Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou, China
  • 3Guangdong Innovative Engineering and Technology Research Center for Assisted Circulation, Shenzhen, China
  • 4Department of Cardiology, Huizhou Third People's Hospital, Huizhou, China
  • 5Department of Cardiac Ultrasound, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
  • 6Department of Physical Education, Nanjing University of Finance and Economics, Nanjing, China

Purpose: Enhanced external counterpulsation is a non-invasive treatment that increases coronary flow in patients with coronary artery disease (CAD). However, the acute responses of vascular and blood flow characteristics in the conduit arteries during and immediately after enhanced external counterpulsation (EECP) need to be verified.

Methods: Forty-two patients with CAD and 21 healthy controls were recruited into this study to receive 45 min-EECP. Both common carotid arteries (CCAs), namely, the left carotid (LC) and right carotid (RC), the right brachial (RB), and right femoral (RF) artery were imaged using a Color Doppler ultrasound. The peak systolic velocity (PSV), end-diastolic velocity (EDV), mean inner diameter (ID), resistance index (RI), and mean flow rate (FR) were measured and calculated before, during, and after the 45 min-EECP treatment.

Results: During EECP, in the CCAs, the EDV was significantly decreased, while the RI was markedly increased in the two groups (both P < 0.01). However, immediately after EECP, the RI in the RC was significantly lower than that at the baseline in the patients with CAD (P = 0.039). The FR of the LC was markedly increased during EECP only in the CAD patients (P = 0.004). The PSV of the patients with CAD was also significantly reduced during EECP (P = 0.015) and immediately after EECP (P = 0.005) compared with the baseline. Moreover, the ID of the LC, RB, and RF was significantly higher immediately after EECP than that at the baseline (all P < 0.05) in the patients with CAD. In addition, they were also higher than that in the control groups (all P < 0.05). Furthermore, by the subgroup analysis, there were significant differences in the FR, PSV, and RI between females and males during and immediately after EECP (all P < 0.05).

Conclusions: Enhanced external counterpulsation creates different responses of vascular and blood flow characteristics in carotid and peripheral arteries, with more significant effects in both the carotid arteries. Additionally, the beneficial effects in ID, blood flow velocity, RI, and FR after 45 min-EECP were shown only in the patients with CAD. More importantly, acute improvement of EECP in the FR of the brachial artery was showed in males, while the FR and RI of the carotid arteries changed in females.

Introduction

Enhanced external counterpulsation is a non-invasive treatment for patients with stable coronary artery disease (CAD), who are not amenable to standard revascularization procedures, such as percutaneous coronary intervention (1, 2). Several studies have demonstrated that enhanced external counterpulsation (EECP) alleviates symptoms of angina and reduces myocardial ischemia (3, 4). Enhanced external counterpulsation also significantly increased myocardial perfusion and coronary collateral flow in patients with CAD (5, 6). In addition, EECP has been previously shown to increase coronary artery flow velocity (7). However, little is known about whether it can affect vascular and blood flow characteristic variables in conduit arteries such as the carotid and those of the limbs, as the pathogenesis and progression of CAD are influenced not only by the behavior of the coronary arteries but also by other more peripheral systemic vessels (8).

These alterations of peripheral vascular and blood flow characteristics play a key role in the modulation of central arterial function, cardiac load, and myocardial perfusion (9). For instance, lower peak systolic velocity (PSV), higher resistance index (RI), and lower end-diastolic velocity (EDV) in the common carotid artery (CCA) are related to adverse cardiovascular events (1012). Studies showed that the left and right CCA may exhibit different prognostic values in the investigated population (13, 14). Due to the different anatomical origins of the left and the right CCA, it was speculated that hemodynamics would have different effects depending on whether the left carotid (LC) or right carotid (RC) artery was considered (15). Brachial artery blood flow velocities are associated with carotid atherosclerosis (16). More importantly, the presence of atherosclerotic plaques and altered vascular function in the aorta, femoral, and carotid arteries are strong predictors of CAD (17).

Nevertheless, there have been few studies on the effects of EECP on conduit artery vascular and blood flow characteristics, and the controversy remains even in patients with CAD. It has been reported that EECP can increase the peak limb blood flow and improve the endothelium-dependent vasodilation in the resistance arteries (18). A similar improvement has been shown in the femoral and brachial arteries (19). Enhanced external counterpulsation can also reduce carotid vascular resistance (9). Whereas, others have found that EECP does not affect the central and peripheral arterial stiffness (20). It has also been reported that the cerebral mean flow velocities increased in patients with stroke during EECP, while it remained unchanged in the elderly controls (21).

Given the controversial reports of the effects of EECP on systemic circulation, this study aimed to investigate the acute effects of EECP on the vascular and blood flow characteristics in the carotid, brachial, and femoral arteries in patients with CAD. Meanwhile, to further explore the mechanisms of these effects, we also aimed to compare the responses to those of the controls at the baseline, during, and immediately after 45 min-EECP.

Materials and Methods

Participants

We enrolled patients with CAD to EECP treatment, diagnosed by angiographically proven stenosis ≥50% in at least one major coronary artery. They were admitted to the Department of Cardiovascular Medicine of the Eighth Affiliated Hospital of Sun Yat-sen University. The exclusion criteria were contraindications for EECP, including uncontrolled hypertension (SBP ≥ 180 mmHg and/or DBP ≥ 100 mmHg), carotid dissection, and deep vein thrombosis at lower extremities. In addition, we recruited healthy people as the control through the Health Examination Center of the Eighth Affiliated Hospital of Sun Yat-sen University. After explaining the purpose of this study and the potential risks, all the participants provided written informed consent. This study was conducted in accordance with the Declaration of Helsinki and was approved by the medical ethics committee of the Eighth Affiliated Hospital of Sun Yat-sen University.

Procedures

All participants received a single, 45-min session of EECP treatment. They lay supine on the EECP treatment bed with their legs and buttocks wrapped in cuffs, which were sequentially inflated from the lower to the upper thigh and buttocks at the beginning of the diastolic phase, followed by a quick, simultaneous deflation of all the cuffs just before the onset of systole. The EECP was conducted using an Oxygen Saturation Monitoring Enhanced External Counterpulsation Instrument (PSK P-ECP/TM, Chongqing, China). The pressure generated by the device was 0.028–0.033 MPa (212.8–250.8 mmHg).

Measurement of Peripheral Vascular and Blood Flow Characteristics

A Color Doppler Ultrasound (GE logic E) examination was performed 10 min before the start of the EECP at 15–25 min after its start and 30 s−1 min immediately after the end of the session. The measurement time for each part was about 2 min and the measurements were performed in the order: RC, LC, right brachial (RB), and right femoral (RF) arteries (19, 22). The right and left CCAs were scanned 1.5 cm proximal to the internal-external carotid bifurcation. The RB and RF measurement sites were fixed approximately 5 cm above the antecubital fossa and 2 cm below the inguinal ligament, respectively. The RF artery was not measured during the EECP because the legs and buttocks on this side were wrapped in the cuffs.

Variables Calculation

The variables, PSV, RI, peak diastolic velocity (VD), PSV/VD (VS/VD), and velocity-time integral (VTI) in the CCAs were continuously recorded for 10 s and then were tracked and calculated.

The mean inner diameters (ID) of all the arteries were calculated as

ID-=(IDdia+IDsys)/2,    (1)

where IDsys and IDdia are the systolic and diastolic diameters, respectively.

The RI was analyzed only in the carotid arteries because, as a measure of cerebral resistance, it is closely associated with cardiovascular risk. It was calculated as

RI=(Vpeak-Vend-dia)/Vpeak,    (2)

where Vpeak is the PSV and Venddia is the EDV.

The mean flow rate (FR) was calculated from the vessel diameter, cardiac period, and velocity-time integral as

FR-=(14π(ID)-×VTI)/t    (3)

where VTI is the averaged velocity-time integral, and t is the averaged cardiac cycle time.

Statistical Analysis

The results are expressed as means ± SE. The normal distribution for all the vascular and blood flow characteristic variables was evaluated by a Kolmogorov–Smirnov test. The basic characteristics of the two groups were compared by an independent t-test. A Chi-square test was also used for the analysis of the gender and risk factors in the two groups. The dependent variables before, during, and after the 45-min EECP, and between the patients with CAD and controls were analyzed by two repeated measures-ANOVA. Gender was regarded as a covariate in the two-way ANOVA of the inter and intra groups. In addition, the hemodynamic variables in each artery were also performed by subgroup analysis of gender. The post hoc analysis was conducted using Fisher's least significant difference. The software SPSS version 20.0 (IBM SPSS Statistics, Armonk, New York, United States) was used for all the statistical tests, and P < 0.05 was taken as a measure of statistical significance.

Results

The basic information of the two groups is listed are Table 1. There were 42 patients with CAD and 21 healthy controls in the study. There were no significant differences between them in number, age, height, weight, and body mass index (BMI) (p > 0.05), while significant differences appeared in gender and risk factors in this study (P < 0.05).

TABLE 1
www.frontiersin.org

Table 1. Base information and major cardiovascular risk factors in the two groups.

The ultrasound picture and Doppler spectrum of carotid and brachial arteries during EECP are presented in Figures 1, 2, respectively. The effect of EECP on the measured variables varied in each artery as did the differences between the patients with CAD and controls are illustrated in Figures 37. In addition, the significant differences in the hemodynamic parameters in females and males of both groups were analyzed by subgroup analysis. These results are shown in Table 2.

FIGURE 1
www.frontiersin.org

Figure 1. Measurement of blood flow velocity spectrum in the right common carotid artery (CCA) [A before enhanced external counterpulsation (EECP) and B during EECP].

FIGURE 2
www.frontiersin.org

Figure 2. Measurement of blood flow velocity spectrum in the right brachial (RB) artery (A before EECP and B during EECP).

FIGURE 3
www.frontiersin.org

Figure 3. Effect of EECP on the mean inner diameters (ID) of the left and right carotid artery (RC/LC) (A,B), RB (C), and right femoral (RF) artery (D) in the patients with coronary artery disease (CAD) and controls before, during, and after a 45 min-EECP. a indicates significant differences in measurements obtained during EECP vs. pre-EECP; b indicates differences between post-EECP vs. during-EECP, and c refers to comparisons between post-EECP vs. pre-EECP. “*” and “**” denote p < 0.5 and < 0.01 respectively. “+” and “++” denote p-values of the difference between groups < 0.5 and < 0.01, respectively.

TABLE 2
www.frontiersin.org

Table 2. Significant differences of the hemodynamic variables for the patients with CAD and controls by subgroup analysis.

Mean ID

During EECP, the ID of the LC was significantly increased compared with the baseline in the patients with CAD (P = 0.013, Figure 3B). Immediately after EECP, the ID of the LC, RB, and RF was significantly higher than that at the baseline (all P < 0.05) in the patients with CAD. In addition, the ID of the patients with CAD in the carotid, brachial and femoral arteries was also higher than that in the control groups (all P < 0.05, Figure 3). However, there was no significant difference in the ID of the controls during and immediately after EECP (all P > 0.05).

PSV

The PSV of the LC was significantly reduced during (P = 0.015) and after EECP (P = 0.005) compared with the baseline in the patients with CAD. However, in the control group, the PSV in the RC and RB was significantly decreased after and during EECP, respectively. These results are illustrated in Figure 4. Based on the subgroup analysis of gender, there was a different pattern in the PSV of the LC and RB between males and females immediately after EECP (both P < 0.05, Table 2).

FIGURE 4
www.frontiersin.org

Figure 4. Effect of EECP on the peak systolic velocity (PSV) of the RC and LC (A,B), RB (C), and RF (D) in the patients with CAD and controls before, during, and after a 45 min-EECP. a indicates significant differences in measurements obtained during EECPvs. pre-EECP; c refers to comparisons between post-EECP vs. pre-EECP. * and ** denote p < 0.5 and < 0.01 respectively.

EDV

The EDV in the CCAs significantly decreased in the two groups during EECP, and then markedly increased following the 45 min-EECP (all P < 0.01, Figure 5). Additionally, during EECP, the EDV of the RC was lower in the patients with CAD than in the controls (P = 0.000, Figure 5A). The EDV in the RB was significantly reduced compared with the baseline only in the patients with CAD (P = 0.000, Figure 5C). However, there was no significant difference in the EDV of the RF immediately after EECP in the two groups (P > 0.05, Figure 5D).

FIGURE 5
www.frontiersin.org

Figure 5. Effect of EECP on the end-diastolic velocity (EDV) of RC and LC (A,B), RB (C), and RF (D) in the patients with CAD and controls before, during, and after a 45 min-EECP. a indicates significant differences in measurements obtained during EECP vs. pre-EECP; b indicates differences between post-EECP vs. during-EECP. ** and ++ denote p-values < 0.01 of the difference between groups.

RI

In the carotid arteries, there was a significant increase in the RI during EECP both in the patients and controls (Figure 6). However, in the RC, the effect was maintained when measured at the end of the treatment period only in the patients with CAD (P = 0.039, Figure 6A). Moreover, the baseline values of the patients were not significantly higher than those of the controls but differ in the RC during (P = 0.002) and immediately after EECP (P = 0.036, Figure 6A). Furthermore, by the subgroup analysis of gender, the RI in the RC was significantly lower immediately after EECP compared with the baseline only in females with CAD (0.703 ± 0.016 vs. 0.731 ± 0.014, P = 0.002, Table 2), while the same change in the RI of the LC was shown only in healthy men (0.723 ± 0.013 vs. 0.682 ± 0.009, P = 0.044, Table 2).

FIGURE 6
www.frontiersin.org

Figure 6. Effect of EECP on the resistance index (RI) of RC (A) and LC (B) in the patients with CAD and controls before, during, and after a 45 min-EECP. a indicates significant differences in measurements obtained during EECP vs. pre-EECP; b indicates differences between post-EECP vs. during-EECP, and c refers to comparisons between post-EECP vs. pre-EECP. * and ** denote p < 0.5 and < 0.01 respectively. + and ++ denote p-values of the difference between groups < 0.5 and < 0.01, respectively.

Mean FR

The FR of the LC was significantly increased during EECP, and then markedly recovered to the baseline in the patients with CAD (both P < 0.01, Figure 7B). It led to a significant difference in the FR between the patients with CAD and controls during EECP (P = 0.029). The FR in the RC was significantly reduced immediately after EECP compared with during EECP only in the controls. Contralaterally, the FR in the RB was markedly higher immediately after EECP than that during EECP in both groups (all P < 0.01, Figure 7C). By the subgroup analysis, the FR of the LC was markedly elevated during EECP in the females with CAD (879.522 ± 60.419 vs. 779.718 ± 50.483, P = 0.021). By contrast, the FR of the RB was significantly increased in the healthy males and those with CAD during and immediately after EECP (all P < 0.05, Table 2).

FIGURE 7
www.frontiersin.org

Figure 7. Effect of EECP on the flow rate (FR) of RC and LC (A,B), RB (C), and RF (D) in the patients with CAD and controls before, during, and after a 45 min-EECP. a indicates significant differences in measurements obtained during EECP vs. pre-EECP; b indicates differences between post-EECP vs. during-EECP. * and ** denote p < 0.5 and < 0.01 respectively. + denotes p-values of the difference between groups < 0.5.

Discussion

This study was designed to investigate the responses of the carotid and peripheral artery vascular and blood flow characteristics to EECP, both during and after a 45 min-session EECP. During EECP, there were different responses of ID, PSV, and FR in the CCAs and RB. Additionally, immediately after EECP, the ID of the LC, RB, and RF was significantly higher, while the PSV of the LC and the RI of the RC were significantly lower than those at the baseline only in the patients with CAD. Moreover, the RI and FR of the carotid arteries were changed in females, while a significant difference in the FR of the RB was shown in males.

In this study, a significant effect on the ID in the LC was observed in the patients with CAD. Additionally, immediately after EECP, the ID of the carotid and peripheral arteries was significantly higher than that at the baseline only in the patients with CAD. Importantly, they were also higher than those in the control groups. Previous large-scale studies have reported that carotid artery response is closely associated with coronary heart disease (23, 24). In addition, a study supported the present findings that EECP had arterial effects on large and small vessels of the carotid circulation in patients with CAD (9). One possible mechanism is by decreasing arterial pressure (25), the other mechanism is EECP, as well as physical training, may also activate the catecholamines and/or metabolic vasodilator pathways (9). A study also demonstrated that femoral artery diameter and vascular shear stress were significantly increased after supervised exercise training (26). Studies have also shown that changes in shear rate led by femoral artery vascular tone elicit an increased femoral baseline diameter after EECP intervention (19). More importantly, studies have demonstrated that endothelial functional changes induced by the shear rate in the peripheral circulations were modestly correlated with changes in the coronary flow reserve (27). The acute increase of ID in the patients with CAD may be related to the effects of peripheral function on the coronary circulation in this study (28).

There were some controversies in the changes of ID in the RB and RF during and immediately after EECP. Zhang et al. found that EECP did not cause an increase in the internal diameter of the RB (29). Gurovich et al. reported that peak diameter was also not increased, while absolute change (mm) of the brachial and femoral arteries significantly increased immediately after EECP (19). They found that the change of the brachial artery diameter affected the improvement of the brachial flow-mediated dilation (FMD), which was closely related to an increase in the brachial artery shear stress (19). Studies have suggested that both flow- and pressure-induced forces played an important role in vessel wall diameter (3032). Inflation of the EECP cuffs can produce high-pressure retrograde blood flow in the femoral arteries and simultaneous moderate-pressure antegrade flow in the brachial arteries (29, 33). The brachial blood flow velocity in the diastole increased by 132% and led to the increase of the brachial artery wall shear stress (29). Cai et al. observed a 1.2-fold increase in femoral artery retrograde blood flow velocity (34). In this study, the PSV of the patients with CAD was significantly reduced during and after EECP compared with the baseline. In addition, the PSV of the RB and EDV of the carotid and peripheral arteries also significantly decreased in the patients with CAD.

Although few studies have focused on blood flow velocity during EECP, the use of an intra-aortic balloon pump, which has some similar mechanisms of action to EECP, induced a decrease of carotid PSV, and an increase in mean blood flow velocity (35) which supports the findings that cerebral flow velocity in the systole is significantly decreased during EECP both in the patients and controls (36). This was attributed to the decreased systolic blood pressure and enhanced cerebral vascular autoregulation (36). Furthermore, decreased systolic blood pressure reduces cardiac afterload after deflation, resulting in decreased PSV. Immediately after EECP, there was no significant difference in the systolic flow velocity in both the patients and controls (36). By contrast, we found that the PSV and EDV of the LC and the RI of the RC were significantly lower than those at the baseline immediately after EECP. Some studies consisted of our findings that EECP increased the cerebral peak velocity in diastole both in the patients and controls (21, 36). It has been shown that improved carotid flow following EECP is associated with decreased arterial stiffness and resistance, dependent upon arterial pressure, modulation of smooth muscle activity, and shear stress (9). More importantly, other investigations suggested that a better coronary vasodilatory response was associated with well-functioning endothelium and blood flow velocity (28).

Some studies have found that blood flow velocity is a parameter related to the arterial diameter, RI, and blood flow (37). More importantly, studies also reported that the regulation of steady blood flow is associated with carotid diameters and blood flow velocity (38). In the present study, there were different responses from the vascular and blood flow characteristics in the CCAs and RB during and immediately after EECP. The FR of the LC was significantly increased during EECP in the patients with CAD. It led to a significant difference in the FR between the patients with CAD and controls during EECP. The FR in the RC was significantly reduced immediately after EECP compared with during EECP only in the controls. Contralaterally, the FR in the RB was markedly higher immediately after EECP than during EECP in both groups. There were some controversial results in the FR during and immediately after EECP. Levenson et al. (9) found that in patients with CAD, the mean carotid blood flow was significantly increased during EECP. Lin et al. found that the cerebral blood flow of patients with ischemic stroke increased during EECP, but there was no change in the elderly subjects (21). Werner et al. found that EECP induced an augmentation in the cerebral blood flow both in the patients and controls (36). Cerebral autoregulation plays an important role in guaranteeing the constancy of cerebral perfusion during EECP (39). The increased FR in the RB after EECP may be related to the increase of the brachial artery wall shear stress (29).

We also found that the FR in the LC was higher than in the RC during and after the 45 min-EECP. This result was consistent with previous findings that the prognostic power of the altered vascular and blood flow characteristics for cardiovascular events is greater in the right CCA than the left (13, 14). Furthermore, the FR of the LC was markedly elevated during EECP in females with CAD. By contrast, the FR in the RB was significantly increased in healthy males and those with CAD during and immediately after EECP. Studies found that cardiovascular function during exercise is also affected by gender (40, 41). Meanwhile, the blood pressure and total peripheral resistance during exercise are higher in women than in men. They thought that the vasodilatory capacity of active muscle groups plays an important role in the cardiovascular differences between women and men (42).

In the study, the RI of the RC was also significantly lower immediately after EECP compared with the baseline only in females with CAD. The decrease of the RI which is strongly associated with cerebrovascular resistance can predict the degree of atherosclerosis and is also beneficial to the increase of blood flow (42, 43). Although the RI significantly increased during EECP, it recovered quickly after the treatment stopped. More importantly, the RI of the right CCA was lower after treatment than the pre-EECP values in the patients with CAD. Our results support those of a previous study that short-term EECP reduces the β-stiffness index and carotid vascular resistance in patients with CAD (9). In addition, studies reported that EECP can reduce distal brain resistance and increase cerebral perfusion (21). It suggests that the benefits of EECP may be attributable to the global improvement of cerebral perfusion (44). Moreover, cerebral autoregulation confirms the constancy of cerebral blood flow under fluctuant cerebral perfusion pressure (39). Furthermore, decreased RI elevates peripheral vascular function, which may, in turn, induce an improvement of the diastolic flow pattern in the coronary arteries (45). Indeed, reduced RI is an important reason for the improvement of carotid hemodynamics in patients with CAD.

Limitations

Some limitations of the present study should be emphasized. Firstly, the sample size was relatively small. Secondly, the order of the measurements after the EECP was femoral, brachial, RC, and LC artery to firstly observe the blood flow from the legs which was directly pressurized during and after EECP. Therefore, at the end of the treatment, the recovery time was minimal for the femoral and increased by 30 s−1 min for each subsequent measurement site. Thirdly, we did not continuously measure these arteries at 1–2 min after EECP. Further study is needed to investigate the duration of the effect on these muscular arteries.

Conclusions

Enhanced external counterpulsation creates different acute responses from the inner diameters, blood flow velocity, and FR between the carotid and peripheral arteries, with more obvious effects in both carotid arteries. Additionally, after the 45-min EECP, the more sustained effects in the inner diameters, RI, blood flow velocity, and FR were shown only in the patients with CAD. Moreover, an acute improvement brought by EECP to the FR of the brachial artery and blood flow velocity of the carotid artery showed in men, while the FR and RI of carotid arteries changed in females. This indicated that EECP should be conducted with different counterpulsation modes, separately intervening carotid arteries and peripheral arteries. More importantly, these findings suggest that EECP can regulate the vascular and blood flow characteristics of conduit arteries, and further improve the carotid and peripheral function in patients with CAD.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by Medical Ethics Committee of the Eighth Affiliated Hospital of Sun Yat-sen University. The patients/participants provided their written informed consent to participate in this study.

Author Contributions

YZ and GW proposed the scientific problems. YZ, GW, and JD designed the experiments. YZ, ZM, ZC, WZ, and HW collected the experimental data. YZ and XZ processed and calculated the data. YZ conducted the statistical analysis and wrote the draft manuscript. WW and GW contributed to the revision and final version of the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was, in part, supported by the National Natural Science Foundation of China (Grant No. 819770367 and 81670417) and the National Key Research and Development Program of China (No. 2020YFC2004400).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Bonetti PO, Holmes DR, Lerman A, Barsness GW. Enhanced external counterpulsation for ischemic heart disease. J Am Coll Cardiol. (2003) 41:1918–25. doi: 10.1016/S0735-1097(03)00428-5

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Members TF, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. (2013) 34:2949–3003. doi: 10.1093/eurheartj/eht296

PubMed Abstract | CrossRef Full Text

3. Lawson WE, Hui JC, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, et al. Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol. (1992) 70:859–62. doi: 10.1016/0002-9149(92)90727-G

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Kim MC, Kini A, Sharma SK. Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol. (2002) 39:923–34. doi: 10.1016/S0735-1097(02)01716-3

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Masuda D, Nohara R, Hirai T, Kataoka K, Chen L, Hosokawa R, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Evaluation by13N-ammonia positron emission tomography. Eur Heart J. (2001) 22:1451–8. doi: 10.1053/euhj.2000.2545

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Gloekler S, Meier P, de Marchi SF, Rutz T, Traupe T, Rimoldi SF, et al. Coronary collateral growth by external counterpulsation: a randomised controlled trial. Heart. (2010) 96:202–7. doi: 10.1136/hrt.2009.184507

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and doppler flow during enhanced external counterpulsation. Circulation. (2002) 106:1237–42. doi: 10.1161/01.CIR.0000028336.95629.B0

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation. (1989) 80:78–86. doi: 10.1161/01.CIR.80.1.78

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Levenson J, Simon A, Megnien JL, Chironi G, Gariepy J, Pernollet MG, et al. Effects of enhanced external counterpulsation on carotid circulation in patients with coronary artery disease. Cardiology. (2007) 108:104–10. doi: 10.1159/000095949

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Bai CH, Chen JR, Chiu HC, Pan WH. Lower blood flow velocity, higher resistance index, and larger diameter of extracranial carotid arteries are associated with ischemic stroke independently of carotid atherosclerosis and cardiovascular risk factors. J Clin Ultrasound. (2007) 35:322–30. doi: 10.1002/jcu.20351

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Ozari HO, Oktenli C, Celik S, Tangi F, Ipcioglu O, Terekeci HM, et al. Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? J Clin Ultrasound. (2012) 40:335–40. doi: 10.1002/jcu.21927

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Chuang SY, Bai CH, Cheng HM, Chen JR, Yeh WT, Hsu PF, et al. Common carotid artery end-diastolic velocity is independently associated with future cardiovascular events. Eur J Prev Cardiol. (2016) 23:116–24. doi: 10.1177/2047487315571888

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Lee SW, Hai JJ, Kong SL, Lam YM, Lam S, Chan PH, et al. Side differences of carotid intima-media thickness in predicting cardiovascular events among patients with coronary artery disease. Angiology. (2011) 62:231–6. doi: 10.1177/0003319710379109

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Loizou CP, Nicolaides A, Kyriacou E, Georghiou N, Griffin M, Pattichis CS. A comparison of ultrasound intima-media thickness measurements of the left and right common carotid artery. IEEE J Transl Eng Health Med. (2015) 3:1900410. doi: 10.1109/JTEHM.2015.2450735

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Luo X, Yang Y, Cao T, Li Z. Differences in left and right carotid intima-media thickness and the associated risk factors. Clin Radiol. (2011) 66:393–8. doi: 10.1016/j.crad.2010.12.002

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Jarhult SJ, Sundstrom J, Lind L. Brachial artery hyperemic blood flow velocities are related to carotid atherosclerosis. Clin Physiol Funct I. (2009) 29:360–5. doi: 10.1111/j.1475-097X.2009.00879.x

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol. (1997) 80:1429–33. doi: 10.1016/S0002-9149(97)00701-7

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Avery JC, Beck DT, Casey DP, Sardina PD, Braith RW. Enhanced external counterpulsation improves peripheral resistance artery blood flow in patients with coronary artery disease. Appl Physiol Nutr Metab. (2014) 39:405–8. doi: 10.1139/apnm-2013-0309

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Gurovich AN, Braith RW. Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans. Hypertens Res. (2013) 36:297–305. doi: 10.1038/hr.2012.169

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Dockery F, Rajkumar C, Bulpitt CJ, Hall RJ, Bagger JP. Enhanced external counterpulsation does not alter arterial stiffness in patients with angina. Clin Cardiol. (2004) 27:689–92. doi: 10.1002/clc.4960271206

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Lin W, Xiong L, Han J, Leung TW, Soo YO, Chen X, et al. External counterpulsation augments blood pressure and cerebral flow velocities in ischemic stroke patients with cerebral intracranial large artery occlusive disease. Stroke. (2012) 43:3007–11. doi: 10.1161/STROKEAHA.112.659144

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Zheng ZS, Li TM, Kambic H, Chen GH, Yu LQ, Cai SR, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs. (1983) 29:599–603.

PubMed Abstract | Google Scholar

23. Kallikazaros I, Tsioufis C, Sideris S, Stefanadis C, Toutouzas P. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke. (1999) 30:1002–7. doi: 10.1161/01.STR.30.5.1002

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Sedaghat S, van Sloten TT, Laurent S, London GM, Pannier B, Kavousi M, et al. Common carotid artery diameter and risk of cardiovascular events and mortality: pooled analyses of four cohort studies. Hypertension. (2018) 72:85–92. doi: 10.1161/HYPERTENSIONAHA.118.11253

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Armentano R, Simon A, Levenson J, Chau NP, Megnien JL, Pichel R. Mechanical pressure versus intrinsic effects of hypertension on large arteries in humans. Hypertension. (1991) 18:657–64. doi: 10.1161/01.HYP.18.5.657

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Dopheide JF, Rubrech J, Trumpp A, Geissler P, Zeller GC, Schnorbus B, et al. Supervised exercise training in peripheral arterial disease increases vascular shear stress and profunda femoral artery diameter. Eur J Prev Cardiol. (2017) 24:178–91. doi: 10.1177/2047487316665231

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Hägg U, Wandt B, Bergström G, Volkmann R, Gan LM. Physical exercise capacity is associated with coronary and peripheral vascular function in healthy young adults. Am J Physiol Heart Circ Physiol. (2005) 289:H1627–34. doi: 10.1152/ajpheart.00135.2005

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Al-Badri A, Kim JH, Liu C, Mehta PK, Quyyumi AA. Peripheral microvascular function reflects coronary vascular function. Arterioscler Thromb Vasc Biol. (2019) 39:1492–500. doi: 10.1161/ATVBAHA.119.312378

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Zhang Y, He X, Chen X, Ma H, Liu D, Luo J, et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. (2007) 116:526–34. doi: 10.1161/CIRCULATIONAHA.106.647248

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation. (2003) 10:83–97. doi: 10.1080/mic.10.1.83.97

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res. (2004) 95:449–58. doi: 10.1161/01.RES.0000141145.78900.44

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol. (2003) 23:1143–51. doi: 10.1161/01.ATV.0000069625.11230.96

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Ozawa ET, Bottom KE, Xiao X, Kamm RD. Numerical simulation of enhanced external counterpulsation. Ann Biomed Eng. (2001) 29:284–97. doi: 10.1114/1.1359448

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Cai D, Wu R, Shao Y. Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med. (2000) 23:239–47. doi: 10.1038/sj.cgt.7700222

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Applebaum RM, Wun HH, Katz ES, Tunick PA, Kronzon I. Effects of intraaortic balloon counterpulsation on carotid artery blood flow. Am Heart J. (1998) 135(Pt. 1):850–4. doi: 10.1016/S0002-8703(98)70045-6

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Werner D, Marthol H, Brown CM, Daniel WG, Hilz MJ. Changes of cerebral blood flow velocities during enhanced external counterpulsation. Acta Neurol Scand. (2003) 107:405–11. doi: 10.1034/j.1600-0404.2003.00074.x

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Schmidt-Trucksass A, Grathwohl D, Schmid A, Boragk R, Upmeier C, Keul J, et al. Structural, functional, and hemodynamic changes of the common carotid artery with age in male subjects. Arterioscler Thromb Vasc Biol. (1999) 19:1091–7. doi: 10.1161/01.ATV.19.4.1091

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Levenson JA, Simon AC, Safar ME. Vasodilatation of small and large arteries in hypertension. J Cardiovasc Pharmacol. (1985) 7(Suppl. 2):S115–120. doi: 10.1097/00005344-198507002-00022

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Markus HS. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry. (2004) 75:353–61. doi: 10.1136/jnnp.2003.025825

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Hossack KF, Bruce RA. Maximal cardiac function in sedentary normal men and women: comparison of age-related changes. J Appl Physiol Respir Environ Exerc Physiol. (1982) 53:799–804. doi: 10.1152/jappl.1982.53.4.799

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Higginbotham MB, Morris KG, Coleman RE, Cobb FR. Sex-related differences in the normal cardiac response to upright exercise. Circulation. (1984) 70:357–66. doi: 10.1161/01.CIR.70.3.357

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Martin WHIII, Ogawa T, Kohrt WM, Malley MT, Korte E, Kieffer PS, et al. Effects of aging, gender, and physical training on peripheral vascular function. Circulation. (1991) 84:654–64. doi: 10.1161/01.CIR.84.2.654

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Frauchiger B, Schmid HP, Roedel C, Moosmann P, Staub D. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke. (2001) 32:836–41. doi: 10.1161/01.STR.32.4.836

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Liebeskind DS. Collateral circulation. Stroke. (2003) 34:2279–84. doi: 10.1161/01.STR.0000086465.41263.06

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation. (2000) 102:1270–5. doi: 10.1161/01.CIR.102.11.1270

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: enhanced external counterpulsation, carotid arteries, peripheral hemodynamics, coronary artery disease, acute response

Citation: Zhang Y, Chen Z, Mai Z, Zhou W, Wang H, Zhang X, Wei W, Du J and Wu G (2021) Acute Hemodynamic Responses to Enhanced External Counterpulsation in Patients With Coronary Artery Disease. Front. Cardiovasc. Med. 8:721140. doi: 10.3389/fcvm.2021.721140

Received: 06 June 2021; Accepted: 12 October 2021;
Published: 12 November 2021.

Edited by:

Richard Yang Cao, Shanghai Xuhui Central Hospital, China

Reviewed by:

Valdo Jose Dias Da Silva, Universidade Federal do Triângulo Mineiro, Brazil
Ricardo Armentano, Universidad de la República, Uruguay

Copyright © 2021 Zhang, Chen, Mai, Zhou, Wang, Zhang, Wei, Du and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guifu Wu, wuguifu@mail.sysu.edu.cn; Jianhang Du, dujh8@mail.sysu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.